India Genetic Testing Market: NGS Adoption, Government Genomics Push & Forecast 2026-2034

Rising hereditary disease burden and expanding India genetic counseling market access are accelerating diagnostic and prenatal genetic testing adoption nationwide.

According to IMARC Group's report titled "India Genetic Testing Market Size, Share, Trends and Forecast by Type, Technology, Application, and Region, 2026-2034", the report offers a comprehensive analysis of the industry, including genetic testing market share in India, its growth, trends, and regional insights.

The India genetic testing market was valued at USD 1.96 Billion in 2025, expected to reach USD 3.69 Billion by 2034, at a CAGR of 6.48% during the forecast period 2026-2034. The market is experiencing robust growth, fueled by rising awareness of hereditary diseases, growing cancer incidence, and expanding access to advanced molecular diagnostics. Increasing government initiatives promoting genomic research and the widespread adoption of prenatal and newborn screening programs, alongside a steadily maturing India gene expression analysis market, are further stimulating demand across hospital networks and independent diagnostic centers.

Market Key Statistics:

• Current Market Size (2025): USD 1.96 Billion
• Projected Market Size (2034): USD 3.69 Billion
• CAGR: 6.48%
• Forecast Period: 2026-2034
• Diagnostic testing holds the largest market share at 60.0% in 2025, owing to its critical role in identifying genetic disorders and hereditary conditions.
• Molecular testing leads the technology segment with a 45.0% share in 2025, driven by its superior sensitivity in detecting diverse genetic mutations.
• Cancer diagnosis represents the largest application segment with a 35.0% share in 2025, reflecting the rising burden of oncological conditions.
• North India comprises the largest region with a 45.0% share in 2025, backed by dense concentration of tertiary care hospitals and genomic diagnostic centers.

India Genetic Testing Market Trends & Future Outlook

• Rising Adoption of NGS in Clinical Diagnostics: Next-generation sequencing (NGS) platforms enable comprehensive genomic profiling at a fraction of earlier costs, facilitating simultaneous analysis of thousands of genes in a single test run. Under the Genome India Project, the Department of Biotechnology completed sequencing of over 10,000 whole genomes from diverse Indian population cohorts as of February 2024, establishing a national genetic reference database.
• Expansion of Prenatal and Newborn Genetic Screening Programs: Increasing awareness of congenital disorders and government-backed maternal health initiatives are driving rapid expansion of prenatal and newborn genetic screening, with cell-free fetal DNA testing and chromosomal microarray analysis witnessing growing adoption among urban and peri-urban populations.
• Integration of Pharmacogenomics in Personalized Treatment Protocols: The convergence of pharmacogenomics with clinical oncology and cardiology is emerging as a critical trend, with India's premier oncology institutions embedding tumor profiling panels into multidisciplinary treatment protocols for breast, lung, and colorectal cancers.

Why Invest in the India Genetic Testing Market - Key Growth Drivers

• Increasing Burden of Genetic Disorders and Hereditary Diseases: India's demographic structure, characterized by elevated rates of consanguineous marriages in several regional communities, has resulted in high prevalence of autosomal recessive conditions, compounded by a rapidly growing elderly population increasingly susceptible to late-onset genetic conditions.
• Government Initiatives and National Genomic Programs: Government-supported programs under the Indian Council of Medical Research and the Department of Biotechnology are directing investment towards genomic data infrastructure, bioinformatics capabilities, and expansion of the india genetic counseling market through Centers of Excellence in genomics at academic institutions.
• Technological Advancements and Declining Cost of Genetic Testing: Progressive cost reduction in NGS platforms, driven by advances in sequencing chemistry and reagent efficiency, has brought comprehensive genomic analyses within reach of a substantially larger patient population, aided by AI-powered variant classification tools.

Evaluate Market Opportunity with the Business Sample Report

Government Policy Support

• Genome India Project: Led by the Department of Biotechnology, this initiative has sequenced over 10,000 whole genomes from diverse Indian populations, building a national reference database that strengthens diagnostic accuracy and research capacity.
• National Health Mission Newborn Screening: Expanded newborn screening protocols under the National Health Mission are establishing standardized pathways for early identification of metabolic and genetic disorders across participating states.
• ICMR Rare Disease Guidelines: Policy frameworks issued by the Indian Council of Medical Research are creating institutional mandates for genetic testing within public health systems, particularly for rare and inherited conditions.
• Centers of Excellence in Genomics: Government-backed academic Centers of Excellence are strengthening India's research and clinical capacity, training genetic counselors and validating diagnostic pathways nationwide.

Key Market Challenges

• Limited Awareness and Genetic Literacy Among the General Population: Misconceptions about genetic diagnoses and limited understanding of hereditary disease concepts among rural and semi-urban populations constrain proactive uptake and referral volumes.
• Shortage of Trained Genetic Counselors and Clinical Geneticists: India faces a critical shortage of qualified professionals, with the limited number of accredited training programs meaning demand significantly outpaces supply, particularly in tier-2 cities.
• Regulatory and Ethical Concerns Surrounding Genetic Data: Concerns related to data privacy, informed consent, and the absence of a fully standardized regulatory framework can discourage individuals from undergoing testing.

Market Segmentation Breakdown

By Type (Diagnostic Testing Leads Market Expansion)

Diagnostic testing dominates with a market share of 60.0% of the total India genetic testing market in 2025. It serves as the foundational pillar of India's genetic testing ecosystem, confirming or ruling out suspected genetic disorders in symptomatic individuals, with rising availability of comprehensive gene panels and whole-exome sequencing through accredited laboratories.

By Technology (Molecular Testing Powers the Market)

Molecular testing leads with a share of 45.0% of the total India genetic testing market in 2025, driven by its unmatched ability to analyze DNA and RNA for detecting inherited mutations and oncological alterations, with PCR and NGS-based assays the most widely deployed platforms.

By Application (Cancer Diagnosis Dominates)

Cancer diagnosis exhibits a clear dominance with a 35.0% share of the total India genetic testing market in 2025, enabling identification of actionable mutations such as BRCA1/2, EGFR, and ALK genes across oncology centers in India's major cities.

By Region (North India Leads Adoption)

North India represents the leading region with a 45.0% share of the total India genetic testing market in 2025, anchored by the dense concentration of premier academic medical centers and accredited reference laboratories in Delhi-NCR, Chandigarh, and Lucknow.

Competitive Landscape - By IMARC GROUP

The India genetic testing market is characterized by a moderately fragmented competitive landscape, comprising large national reference laboratory networks, multi-specialty hospital-affiliated diagnostic centers, and a growing number of specialized genomic testing providers. Gain comprehensive access to an in-depth analysis of the competitive landscape, including market structure, key player positioning, competitive dashboards, winning strategies, and detailed profiles of all major industry participants within the full research report.

Recent Developments & News

• In February 2026, Genetic Wellness Testing, introduced by NuGenomics, an AI-powered wellness startup, was made available for INR 999, broadening consumer access to affordable wellness-oriented genetic screening.

Request Customized Data Tailored to Your Interest

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Frequently Asked Questions

Q1. How big is the India genetic testing market?

➤ The India genetic testing market was valued at USD 1.96 Billion in 2025, reflecting rapid clinical adoption of genomic diagnostics across the country.

Q2. What is the projected growth rate?

➤ The market is expected to grow at a CAGR of 6.48% from 2026 to 2034, reaching USD 3.69 Billion by 2034, driven by government genomic programs and rising hereditary disease burden.

Q3. Which segment held the largest India genetic testing market share?

➤ Diagnostic testing dominated with a 60.0% share, driven by its critical role in confirming hereditary conditions and growing integration into multidisciplinary clinical pathways.

Strategic Insight & Verdict

The India genetic testing market stands at a pivotal inflection point, where government-backed genomic infrastructure, falling NGS costs, and rising clinical integration across oncology, cardiology, and reproductive medicine are converging to sustain long-term expansion. With a 6.48% CAGR trajectory through 2034 and an increasingly diversified application base, the market presents a high-conviction opportunity for diagnostic laboratories, genomics technology providers, and genetic counseling networks over the forecast decade.

Verified Source: IMARC Group